KARO PHARMA AB'S TAKEOVER OFFER FOR WEIFA ASA SUCCESSFUL
(Thomson Reuters ONE) -
On expiration of the offer period on 3 October, 2017 at 16:30 CEST, Karo Pharma
AB ("Karo Pharma") had received acceptances for the voluntary offer ("Voluntary
Offer") to acquire all shares in Weifa ASA ("Weifa") for a total of 35 414 529
shares representing approximately 97,1% of the total shares in Weifa on a fully
diluted basis. The acceptance level is based on preliminary numbers and may be
subject to adjustments.
Accordingly, the conditions for completion of the Voluntary Offer have been met
and in accordance with the terms and conditions set out in the offer document,
settlement according to the Voluntary Offer will take place as soon as possible
and within 12 October 2017.
"We are very pleased to have reached a high acceptance level of more than 95% of
the shares in Weifa ASA. This is a very important step in creating a profitable
and dynamic Speciality Pharma company out of the Nordics. The synergy potential
is obvious", says Anders Lönner, Chairman of the Board of Karo Pharma AB.
Following settlement of the Voluntary Offer, Karo Pharma intends to initiate a
compulsory acquisition of the remaining outstanding shares of Weifa in
accordance with applicable laws, and to propose that Weifa applies for a
delisting of its shares from Oslo Børs.
For further information, please contact:
Peter Blom, CEO of Karo Pharma, +46 070-655 56 98 or peter.blom(at)karopharma.se
Simen Nyberg-Hansen, CFO of Weifa: +47 9820 6355, or simen.nyberg-
hansen(at)weifa.no
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Weifa ASA via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="VLT Amends Agreement with Lithium Selective Technologies, Inc.
Datum: 03.10.2017 - 18:00 Uhr
Sprache: Deutsch
News-ID 562291
Anzahl Zeichen: 2075
contact information:
Town:
Oslo
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 343 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"KARO PHARMA AB'S TAKEOVER OFFER FOR WEIFA ASA SUCCESSFUL"
steht unter der journalistisch-redaktionellen Verantwortung von
Weifa ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
